Cargando…

Evolution of comorbidities in people living with HIV between 2004 and 2014: cross-sectional analyses from ANRS CO3 Aquitaine cohort

BACKGROUND: The objective of the study was to describe the evolution of chronic non-AIDS related diseases and their risk factors, in patients living with HIV (PLHIV) in the French ANRS CO3 Aquitaine prospective cohort, observed both in 2004 and in 2014 in order to improve long-term healthcare manage...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonnet, F., Le Marec, F., Leleux, O., Gerard, Y., Neau, D., Lazaro, E., Duffau, P., Caubet, O., Vandenhende, M. A., Mercie, P., Cazanave, C., Dabis, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670698/
https://www.ncbi.nlm.nih.gov/pubmed/33198667
http://dx.doi.org/10.1186/s12879-020-05593-4
_version_ 1783610790128910336
author Bonnet, F.
Le Marec, F.
Leleux, O.
Gerard, Y.
Neau, D.
Lazaro, E.
Duffau, P.
Caubet, O.
Vandenhende, M. A.
Mercie, P.
Cazanave, C.
Dabis, F.
author_facet Bonnet, F.
Le Marec, F.
Leleux, O.
Gerard, Y.
Neau, D.
Lazaro, E.
Duffau, P.
Caubet, O.
Vandenhende, M. A.
Mercie, P.
Cazanave, C.
Dabis, F.
author_sort Bonnet, F.
collection PubMed
description BACKGROUND: The objective of the study was to describe the evolution of chronic non-AIDS related diseases and their risk factors, in patients living with HIV (PLHIV) in the French ANRS CO3 Aquitaine prospective cohort, observed both in 2004 and in 2014 in order to improve long-term healthcare management. METHODS: The ANRS CO3 Aquitaine cohort prospectively collects epidemiological, clinical, biological and therapeutic data on PLHIV in the French Aquitaine region. Two cross sectional analyses were performed in 2004 and 2014, to investigate the patient characteristics, HIV RNA, CD4 counts and prevalence of some common comorbidities and treatment. RESULTS: 2138 PLHIV (71% male, median age 52.2 years in 2014) were identified for inclusion in the study, including participants who were registered in the cohort with at least one hospital visit recorded in both 2004 and 2014. Significant increases in the prevalence of diagnosed chronic kidney disease (CKD), bone fractures, cardiovascular events (CVE), hypertension, diabetes and dyslipidaemia, as well as an increase in treatment or prevention for these conditions (statins, clopidogrel, aspirin) were observed. It was also reflected in the increase in the proportion of patients in the “high” or “very high” risk groups of the disease risk scores for CKD, CVE and bone fracture score. CONCLUSIONS: Between 2004 and 2014, the aging PLHIV population identified in the French ANRS CO3 Aquitaine prospective cohort experienced an overall higher prevalence of non-HIV related comorbidities, including CKD and CVD. Long-term healthcare management and long-term health outcomes could be improved for PLHIV by: careful HIV management according to current recommendations with optimal selection of antiretrovirals, and early management of comorbidities through recommended lifestyle improvements and preventative measures.
format Online
Article
Text
id pubmed-7670698
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-76706982020-11-18 Evolution of comorbidities in people living with HIV between 2004 and 2014: cross-sectional analyses from ANRS CO3 Aquitaine cohort Bonnet, F. Le Marec, F. Leleux, O. Gerard, Y. Neau, D. Lazaro, E. Duffau, P. Caubet, O. Vandenhende, M. A. Mercie, P. Cazanave, C. Dabis, F. BMC Infect Dis Research Article BACKGROUND: The objective of the study was to describe the evolution of chronic non-AIDS related diseases and their risk factors, in patients living with HIV (PLHIV) in the French ANRS CO3 Aquitaine prospective cohort, observed both in 2004 and in 2014 in order to improve long-term healthcare management. METHODS: The ANRS CO3 Aquitaine cohort prospectively collects epidemiological, clinical, biological and therapeutic data on PLHIV in the French Aquitaine region. Two cross sectional analyses were performed in 2004 and 2014, to investigate the patient characteristics, HIV RNA, CD4 counts and prevalence of some common comorbidities and treatment. RESULTS: 2138 PLHIV (71% male, median age 52.2 years in 2014) were identified for inclusion in the study, including participants who were registered in the cohort with at least one hospital visit recorded in both 2004 and 2014. Significant increases in the prevalence of diagnosed chronic kidney disease (CKD), bone fractures, cardiovascular events (CVE), hypertension, diabetes and dyslipidaemia, as well as an increase in treatment or prevention for these conditions (statins, clopidogrel, aspirin) were observed. It was also reflected in the increase in the proportion of patients in the “high” or “very high” risk groups of the disease risk scores for CKD, CVE and bone fracture score. CONCLUSIONS: Between 2004 and 2014, the aging PLHIV population identified in the French ANRS CO3 Aquitaine prospective cohort experienced an overall higher prevalence of non-HIV related comorbidities, including CKD and CVD. Long-term healthcare management and long-term health outcomes could be improved for PLHIV by: careful HIV management according to current recommendations with optimal selection of antiretrovirals, and early management of comorbidities through recommended lifestyle improvements and preventative measures. BioMed Central 2020-11-16 /pmc/articles/PMC7670698/ /pubmed/33198667 http://dx.doi.org/10.1186/s12879-020-05593-4 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Bonnet, F.
Le Marec, F.
Leleux, O.
Gerard, Y.
Neau, D.
Lazaro, E.
Duffau, P.
Caubet, O.
Vandenhende, M. A.
Mercie, P.
Cazanave, C.
Dabis, F.
Evolution of comorbidities in people living with HIV between 2004 and 2014: cross-sectional analyses from ANRS CO3 Aquitaine cohort
title Evolution of comorbidities in people living with HIV between 2004 and 2014: cross-sectional analyses from ANRS CO3 Aquitaine cohort
title_full Evolution of comorbidities in people living with HIV between 2004 and 2014: cross-sectional analyses from ANRS CO3 Aquitaine cohort
title_fullStr Evolution of comorbidities in people living with HIV between 2004 and 2014: cross-sectional analyses from ANRS CO3 Aquitaine cohort
title_full_unstemmed Evolution of comorbidities in people living with HIV between 2004 and 2014: cross-sectional analyses from ANRS CO3 Aquitaine cohort
title_short Evolution of comorbidities in people living with HIV between 2004 and 2014: cross-sectional analyses from ANRS CO3 Aquitaine cohort
title_sort evolution of comorbidities in people living with hiv between 2004 and 2014: cross-sectional analyses from anrs co3 aquitaine cohort
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670698/
https://www.ncbi.nlm.nih.gov/pubmed/33198667
http://dx.doi.org/10.1186/s12879-020-05593-4
work_keys_str_mv AT bonnetf evolutionofcomorbiditiesinpeoplelivingwithhivbetween2004and2014crosssectionalanalysesfromanrsco3aquitainecohort
AT lemarecf evolutionofcomorbiditiesinpeoplelivingwithhivbetween2004and2014crosssectionalanalysesfromanrsco3aquitainecohort
AT leleuxo evolutionofcomorbiditiesinpeoplelivingwithhivbetween2004and2014crosssectionalanalysesfromanrsco3aquitainecohort
AT gerardy evolutionofcomorbiditiesinpeoplelivingwithhivbetween2004and2014crosssectionalanalysesfromanrsco3aquitainecohort
AT neaud evolutionofcomorbiditiesinpeoplelivingwithhivbetween2004and2014crosssectionalanalysesfromanrsco3aquitainecohort
AT lazaroe evolutionofcomorbiditiesinpeoplelivingwithhivbetween2004and2014crosssectionalanalysesfromanrsco3aquitainecohort
AT duffaup evolutionofcomorbiditiesinpeoplelivingwithhivbetween2004and2014crosssectionalanalysesfromanrsco3aquitainecohort
AT caubeto evolutionofcomorbiditiesinpeoplelivingwithhivbetween2004and2014crosssectionalanalysesfromanrsco3aquitainecohort
AT vandenhendema evolutionofcomorbiditiesinpeoplelivingwithhivbetween2004and2014crosssectionalanalysesfromanrsco3aquitainecohort
AT merciep evolutionofcomorbiditiesinpeoplelivingwithhivbetween2004and2014crosssectionalanalysesfromanrsco3aquitainecohort
AT cazanavec evolutionofcomorbiditiesinpeoplelivingwithhivbetween2004and2014crosssectionalanalysesfromanrsco3aquitainecohort
AT dabisf evolutionofcomorbiditiesinpeoplelivingwithhivbetween2004and2014crosssectionalanalysesfromanrsco3aquitainecohort